Cargando…
Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer
Mycobacterium bovis bacillus Calmette–Guerin (BCG) remains at the forefront of immunotherapy for treating bladder cancer patients. However, the incidence of recurrence and progression to invasive cancer is commonly observed. There are no established effective intravesical therapies available for pat...
Autores principales: | Buss, Julieti Huch, Begnini, Karine Rech, Bender, Camila Bonemann, Pohlmann, Adriana R., Guterres, Silvia S., Collares, Tiago, Seixas, Fabiana Kömmling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770893/ https://www.ncbi.nlm.nih.gov/pubmed/29379438 http://dx.doi.org/10.3389/fphar.2017.00977 |
Ejemplares similares
-
Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell
por: Buss, Julieti Huch, et al.
Publicado: (2019) -
Perspective: Humanized Pig Models of Bladder Cancer
por: Segatto, Natália Vieira, et al.
Publicado: (2021) -
The Potential of Nanotechnology in Medically Assisted Reproduction
por: Remião, Mariana H., et al.
Publicado: (2018) -
Brazilian Red Propolis Induces Apoptosis-Like Cell Death and Decreases Migration Potential in Bladder Cancer Cells
por: Begnini, Karine Rech, et al.
Publicado: (2014) -
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)